Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_assertion type Assertion NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_head.
- NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_assertion description "[Of eligible 159 patients (113 males, 46 females), median age was 53 years old The histological subtypes included peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) 35.8%, angioimmunoblastic T-cell lymphoma (AITL) 18.2%, extranodal NK/T-cell lymphoma (ENKL) 17.0%, subcutaneous panniculitis-like T-cell lymphoma (SPTCL) 12.6%, cutaneous T-cell lymphoma (CTCL) 11.3%, anaplastic large cell lymphoma (ALCL) 4.4%, and enteropathy-associated T-cell lymphoma (EATL) 0.6%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_provenance.
- NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_assertion evidence source_evidence_literature NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_provenance.
- NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_assertion SIO_000772 26638586 NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_provenance.
- NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_assertion wasDerivedFrom befree-2016 NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_provenance.
- NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_assertion wasGeneratedBy ECO_0000203 NP1295697.RAVvA8V1C0KOk613BI_0wKyG5CTBWZRj-bJztNLIw-zoc130_provenance.